Theravance Biopharma Inc TBPH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:05 PM EDT
8.97UNCH (UNCH)
Volume
28,455
Close
8.97quote price arrow down-0.04 (-0.44%)
Volume
373,255
52 week range
8.21 - 12.03
Loading...
  • Open9.00
  • Day High9.00
  • Day Low8.77
  • Prev Close9.01
  • 52 Week High12.03
  • 52 Week High Date04/17/23
  • 52 Week Low8.21
  • 52 Week Low Date02/08/24

Key Stats

  • Market Cap432.037M
  • Shares Out48.16M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-20.2

KEY STATS

  • Open9.00
  • Day High9.00
  • Day Low8.77
  • Prev Close9.01
  • 52 Week High12.03
  • 52 Week High Date04/17/23
  • 52 Week Low8.21
  • 52 Week Low Date02/08/24
  • Market Cap432.037M
  • Shares Out48.16M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta0.36
  • YTD % Change-20.2

RATIOS/PROFITABILITY

  • EPS (TTM)-0.97
  • P/E (TTM)-9.24
  • Fwd P/E (NTM)-11.33
  • EBITDA (TTM)-51.291M
  • ROE (TTM)-16.86%
  • Revenue (TTM)57.424M
  • Gross Margin (TTM)31.69%
  • Net Margin (TTM)-96.11%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Theravance Biopharma Inc

 

Profile

MORE
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is a prescription medicine used to treat COPD, a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps...
Rick Winningham
Chairman of the Board, Chief Executive Officer
Aziz Sawaf
Chief Financial Officer, Senior Vice President
Address
UGLAND HOUSE, SOUTH CHURCH STREET
George Town
KY1-1104
Cayman Islands

Top Peers

SYMBOLLASTCHG%CHG
RCEL
AVITA Medical Inc
16.03-0.47-2.85%
ADCT
ADC Therapeutics SA
4.49+0.29+6.90%
CRBU
Caribou Biosciences Inc
5.14+0.02+0.39%
PSTX
Poseida Therapeutics Inc
3.19+0.11+3.57%
MRNS
Marinus Pharmaceuticals Inc
9.04+0.19+2.15%